Drug and Therapy Development for Triple Negative Breast Cancer

Drug and Therapy Development for Triple Negative Breast Cancer is a comprehensive and up-to-date compilation of modern diagnostic and treatment methods for TNBC. It covers molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and new and experimental therapies, including nanotherapeutics and photothermal therapies. It is an unmatched source of information about current and future treatment approaches, including machine learning methods for earlier detection and more accurate diagnosis.

Format: Hardback
Length: 320 pages
Publication date: 19 July 2023
Publisher: Wiley-VCH Verlag GmbH

In the realm of drug and therapy development for triple negative breast cancer (TNBC), a remarkable resource emerges—the first comprehensive and up-to-date compilation of modern diagnostic and treatment methods. This invaluable guide, penned by a team of distinguished practitioners, delves deep into the complexities of TNBC, offering an in-depth and authoritative discussion of contemporary approaches to treatment.

The editors have meticulously curated a wealth of information, encompassing the molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and emerging therapies, including nanotherapeutics and photothermal therapies. This comprehensive compilation serves as an unparalleled source of knowledge about current and future treatment strategies, including innovative machine learning methods for earlier detection and more accurate diagnosis.

Within its pages, readers will find a thorough introduction to HER receptors in breast cancers, comprehensive explorations of the etiology and therapy of hormone receptor-positive breast cancer, as well as the early-stage diagnosis of breast cancer. Moreover, the application of artificial intelligence to breast cancer diagnosis is explored, shedding new light on this rapidly evolving field.

New insights into the role of DNA replication stress and genome instability in breast cancer are unveiled, providing valuable perspectives for medicinal and pharmaceutical chemists, oncologists, and professionals working in the pharmaceutical industry or hospital settings.

Drug and Therapy Development for Triple Negative Breast Cancer is a indispensable resource for those seeking to stay at the forefront of this critical field. Its comprehensive coverage, expert insights, and practical applications make it a must-have for anyone dedicated to improving the outcomes for patients with TNBC.

Dimension: 244 x 170 (mm)
ISBN-13: 9783527351756